Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USANA

This article was originally published in The Tan Sheet

Executive Summary

Firm announces plans to begin operations in Singapore in Q4 2003. "Singapore represents a strategic location for future expansion throughout Southeast Asia," USANA Pres. Dave Wentz says. The Salt Lake City, Utah-based company presently operates in eight countries outside the U.S. including South Korea and Japan (1"The Tan Sheet" July 21, 2003, p. 13)...

You may also be interested in...



USANA Using “Backwash” Strategy To Enter New Markets, Boost Sales

USANA Health Sciences is leveraging entrance into new markets to spur sales in existing ones as part of its business strategy to grow the top line

Unprecedented To Lawful: Regulatory Precedent Needed For Cannabinoids’ Use In Supplements?

“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”

Colfax Plans To Split To Form Separate Medtech And Fabtech Companies

The yet-to-be-named medtech company will focus on orthopedic implants and bracing and recovery devices.

Topics

UsernamePublicRestriction

Register

LL1135972

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel